Avid Bioservices Inc (CDMO)

[biopharm]

For any new investors lately.... this is a must "hear" from the late Dr Phil Thorpe in May of 2012...and thanks to CJ for posting below:

"Dr. Philip Thorpe’s 46min. 5-1-12 NYAS Anti-PS Symposium talk Replay & Slides – see below. He was the last of these 5 speakers at the NYAS “Phosphatidylserine (PS) Asymmetry - Therapeutic Applications in Cancer & Infectious Disease Symposium. If you have the time to listen to all 5 of these talks, you will learn an immense amount about the moa of Peregrine’s PS-targeting antibody therapeutic, Bavituximab.

https://investorshub.advfn.com/secure/post_reply.aspx?message_id=79851320

------------------------------

I know its not over till the fat lady sings but she has an appointment and the mic will be on for all in attendance to hear. Dr Jedd Wolchok does not take such interest in the MOA of any drug but the question is the MOA of Bavituximab may be unlike any other drug that Dr Wolchok has ever seen before....

...just listen to the late Dr Thorpe for some early insights and let the immune system get back to work

"The Enlightenment Age of Disease" is upon us...